Mitiglinide calcium is a short‑acting oral antidiabetic agent of the “glinide” class, used (mainly in Asia) to improve postprandial glucose control in type 2 diabetes by rapidly stimulating insulin secretion from pancreatic β‑cells. It is grouped under the following drug class(es): Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mitiglinide calcium anhydrous and DTXSID90872410. Its PubChem CID is 5478927.
Mitiglinide Calcium
| CAS No | 145525-41-3 |
|---|---|
| Molecular Formula | C38H48CaN2O6 |
| Molecular Weight | 668.90 g/mol |
| Synonyms | calcium bis((2S)-4-[(3aR,7aS)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate) |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mitiglinide calcium is a short‑acting oral antidiabetic agent of the “glinide” class, used (mainly in Asia) to improve postprandial glucose control in type 2 diabetes by rapidly stimulating insulin secretion from pancreatic β‑cells.
The listed CAS number is 145525-41-3.
The listed molecular formula is C38H48CaN2O6.
The listed molecular weight is 668.90 g/mol.
calcium bis((2S)-4-[(3aR,7aS)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate).
The source lists Mitiglinide calcium anhydrous and DTXSID90872410.